Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

DES Home | For Consumers | For Health Care Providers
For DES Update Partners | Contact Us
DES Update: Consumers

Notice! Content may be out of date
The following content is no longer maintained and may be out of date. Persons with disabilities having difficulty accessing the information on this page may contact cdcinfo@cdc.gov for assistance. Please view the Updated Bibliographies on the Updated Bibliographies page for updated information on this topic.



 Consumers Home
 About DES
 DES Research
 Understanding DES Research
 Recent DES Research
 What You Can Do
 DES Teleconferences
 Additional Resources
 Interactive DES Self-Assessment Guide
 Women Prescribed DES While Pregnant
 DES Daughters
 DES Sons
 DES Third Generation

Email this page
Order DES materials
Download DES materials
Image of a woman using a microscope  DES Research
Consumers Home > DES Research > Recent DES Research > Incidence of Squamous Neoplasia of the Cervix and Vagina in Women Exposed Prenatally to Diethylstibestrol
Incidence of Squamous Neoplasia of the Cervix and Vagina in Women Exposed Prenatally to Diethylstibestrol (United States) (Hatch et al., 2001)

Women exposed to DES before birth (in the womb), known as DES Daughters, are at increased risk for clear cell adenocarcinoma of the vagina and cervix, but the effect of in utero DES exposure on later development of squamous neoplasia in the cervix and vagina is uncertain. This combined follow-up study of 3,899 DES Daughters (median age 38) and 1,374 unexposed daughters (median age 39) was followed 1982-1995. Subjects were drawn from three previously studied cohorts (DESAD, Dieckmann, and Horne). The purpose was to examine the long-term risk of developing high-grade squamous intraepithelial neoplasia (HSIL) of the genital tract in DES Daughters compared with unexposed daughters.

The study found a small but significant increase in HSIL among DES Daughters in all age groups, including those over age 40. A total of 111 pathology-confirmed HSIL cases occurred, including five of the vagina, one of the vulva and two cases of invasive cervical cancer. The overall relative risk was 2.1 among DES-exposed versus unexposed. The relative risk among those whose mothers were prescribed DES within 7 weeks of the last menstrual period was 2.8 compared with 1.35 among women exposed for the first time at 15 weeks or later. Women with documented high-grade neoplasia before 1982 were excluded because prior treatment of the cervix may lower the subsequent finding of intraepithelial neoplasia. Researchers could not rule out that more frequent and intensive screening among DES-exposed women played a role in these findings.

Neoplasia is abnormal and uncontrolled cell growth; a neoplasm is new growth of benign or malignant tissue. Squamous cells are found in the tissue that forms the surface of the skin, the lining of the hollow organs of the body, and the passages of the respiratory and digestive tracts. These flat cells look like fish scales under a microscope. Squamous intraepithelial lesion (SIL) is a general term for the abnormal growth of squamous cells on the surface of the cervix. The changes in the cells are described as low grade or high grade, depending on how much of the cervix is affected and how abnormal the cells appear. Cervical intraepithelial neoplasia (CIN) is a general term for the growth of abnormal cells on the surface of the cervix. Numbers from 1 to 3 may be used to describe how much of the cervix contains abnormal cells. High-grade squamous intraepithelial lesion (HSIL) is a precancerous condition in which the cells of the uterine cervix are moderately or severely abnormal. In this study, grades 2 and 3 were considered high. (Adapted from National Cancer Institute Dictionary, available at URL: http://cancer.gov/dictionary/)

Citation: Hatch EE, Herbst AL, Hoover RN, Noller KL, Adam E, Kaufman RH, et al. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol [United States]. Cancer Causes Control 2001;12:837-845.

   

Recent DES Research

 Overview
WOMEN PRESCRIBED DES WHILE PREGNANT
 Long-Term Cancer Risk in Women Given DES During Pregnancy
DES DAUGHTERS
 Psychosexual Characteristics of Men and Women Exposed Prenatally to Diethylstilbestrol
 Cancer Risk in Women Exposed to DES in Utero
 Continued Follow-Up of Pregnancy Outcomes in DES-Exposed Offspring
 Infertility Among Women Exposed Prenatally to DES
 Incidence of Squamous Neoplasia of the Cervix and Vagina
 Risk of Breast Cancer in Women Exposed to DES in Utero
DES SONS
 Psychosexual Characteristics of Men and Women Exposed Prenatally to Diethylstilbestrol
 Cancer Risk in Men Exposed in Utero to DES
THIRD GENERATION (Offspring of DES Daughters & Sons)
 Findings in Female Offspring of Women Exposed in Utero to DES
 Hypospadias in Sons of Women Exposed to DES in Utero


Back to Top

Contact Us | Site Map | Privacy Policy | Disclaimer | FOIA | Accessibility

CDC Home | Search | Health Topics A-Z



United States Department of Health and Human Services
Centers for Disease Control and Prevention